The Menarini Group, along with its subsidiary Stemline Therapeutics, has announced a partnership with VisualDx to enhance the detection of blastic plasmacytoid dendritic cell neoplasm (BPDCN). The ...

ROCHESTER, N.Y.--(BUSINESS WIRE)--Rochester-based VisualDx, has enhanced its VisualDx app with Core ML, a new framework enabling on-device machine learning to create powerful, rich experiences. The ...

VisualDx is a clinical decision support system used by more than 2,300 hospitals, clinics, and medical schools around the world VisualDx's system seeks to enhance identification of people who may have ...

VisualDx, a health technology company that developed a mobile-based skin cancer assessment tool for clinical decision support and a patient facing website, has teamed up with Science 37 to provide ...

A New York-based company won a grant from the Bill & Melinda Gates Foundation to build a diagnostic tool that can work without an internet connection. VisualDx won a $655,535 grant, which it will use ...

ROCHESTER, N.Y.--(BUSINESS WIRE)--VisualDx, a global leader in web-based clinical decision support (CDS), today announced that it has entered into an agreement with Janssen Biotech, Inc., one of the ...

New partnership improves AI health answers with visual intelligence grounded in real clinical practice Through this partnership, VisualDx serves as the visual intelligence layer within Perplexity that ...

Absolut Skin, a dermatology-led skincare and health-technology platform, has announced its partnership with VisualDx, to bring artificial intelligence (AI) powered skin condition identification and ...

VisualDx's image database leverages the power of visualisation to help physicians worldwide easily differentiate between lesions and morphologies LONDON, March 21, 2019 /PRNewswire/ -- Based on its ...

VisualDx and Perplexity today announced a new partnership that brings clinician-validated medical images directly into AI-powered health answers. VisualDx, a leading clinical decision support system ...